Patent
   D499802
Priority
Apr 01 2003
Filed
Apr 01 2003
Issued
Dec 14 2004
Expiry
Dec 14 2018
Assg.orig
Entity
unknown
86
9
n/a
The ornamental design for a powder inhaler, as shown and described.

FIG. 1 is a side perspective view of a powder inhaler showing our new design, with the cover shown in closed position;

FIG. 2 is a s side perspective view of the powder inhaler shown in FIG. 1 with the cover being disposed in an open position;

FIG. 3 is an elevated right side view of the powder inhaler shown in FIG. 1;

FIG. 4 is an elevated back side view of the powder inhaler shown in FIG. 1;

FIG. 5 is an elevated left side view of the powder inhaler shown in FIG. 2;

FIG. 6 is a top perspective view of the powder inhaler shown in FIG. 2;

FIG. 7 is a top perspective view of a second embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has a violet color, it being understood that all other surfaces are the same as those of the first embodiment;

FIG. 8 is a side perspective view of the powder inhaler shown in FIG. 7 with the cover being disposed in an open position;

FIG. 9 is an elevated right side view of the powder inhaler shown in FIG. 7;

FIG. 10 is an elevated back side view of the powder inhaler shown in FIG. 7;

FIG. 11 is an elevated left side view of the powder inhaler shown in FIG. 8;

FIG. 12 is a top perspective view of the powder inhaler shown in FIG. 8;

FIG. 13 is a top perspective view of a third embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has an orange color, it being understood that all other surfaces are the same as those of the first embodiment;

FIG. 14 is a side perspective view of the powder inhaler shown in FIG. 13 with the cover being disposed in an open position;

FIG. 15 is an elevated right side view of the powder inhaler shown in FIG. 13;

FIG. 16 is an elevated back side view of the powder inhaler shown in FIG. 13;

FIG. 17 is an elevated left side view of the powder inhaler shown in FIG. 14;

FIG. 18 is a top perspective view of the powder inhaler shown in FIG. 14;

FIG. 19 is a top perspective view of a fourth embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has a green color, it being understood that all other surfaces are the same as those of the first embodiment;

FIG. 20 is a side perspective view of the powder inhaler shown in FIG. 19 with the cover being disposed in an open position;

FIG. 21 is an elevated right side view of the powder inhaler shown in FIG. 19;

FIG. 22 is an elevated back side view of the powder inhaler shown in FIG. 19;

FIG. 23 is an elevated left side view of the powder inhaler shown in FIG. 20;

FIG. 24 is a top perspective view of the powder inhaler shown in FIG. 20;

FIG. 25 is a top perspective view of a fifth embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has a burgundy color, it being understood that all other surfaces are the same as those of the first embodiment;

FIG. 26 is a side perspective view of the powder inhaler shown in FIG. 25 with the cover being disposed in an open position;

FIG. 27 is an elevated right side view of the powder inhaler shown in FIG. 25;

FIG. 28 is an elevated back side view of the powder inhaler shown in FIG. 25;

FIG. 29 is an elevated left side view of the powder inhaler shown in FIG. 26;

FIG. 30 is a top perspective view of the powder inhaler shown in FIG. 26;

FIG. 31 is a top perspective view of a sixth embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has a blue color, it being understood that all other surfaces are the same as those of the first embodiment;

FIG. 32 is a side perspective view of the powder inhaler shown in FIG. 31 with the cover being disposed in an open position;

FIG. 33 is an elevated right side view of the powder inhaler shown in FIG. 31;

FIG. 34 is an elevated back side view of the powder inhaler shown in FIG. 31;

FIG. 35 is an elevated left side view of the powder inhaler shown in FIG. 32; and,

FIG. 36 is a top perspective view of the powder inhaler shown in FIG. 32.

Smith, Simon, Smith, Christopher James, Arlett, Ben, Ahern, David, Pinon, John, Shirgaonkar, Sameer, Burge, Simon, Middleton, Max William, Sarkar, Matthew Neil, Lye, Emma Lesley

Patent Priority Assignee Title
10130581, Feb 22 2006 MannKind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
10130685, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
10130709, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
10143655, Sep 14 2005 MannKind Corporation Method of drug formulation
10159644, Oct 26 2012 MannKind Corporation; TechnoVax, Inc. Inhalable vaccine compositions and methods
10172850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
10201672, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
10258664, Oct 24 2011 MannKind Corporation Methods and compositions for treating pain
10307464, Mar 27 2015 MannKind Corporation Use of ultrarapid acting insulin
10342938, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
10421729, Mar 15 2013 MannKind Corporation Microcrystalline diketopiperazine compositions and methods
10561806, Oct 02 2014 MannKind Corporation Mouthpiece cover for an inhaler
10625034, Apr 01 2011 MannKind Corporation Blister package for pharmaceutical cartridges
10675421, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
10751488, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
11446127, Aug 05 2013 MannKind Corporation Insufflation apparatus and methods
8424518, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
8485180, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
8499757, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
8636001, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
8912193, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9192675, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9220687, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
9233159, Oct 24 2011 MannKind Corporation; Torrey Pines Institute for Molecular Studies Methods and compositions for treating pain
9241903, Feb 22 2006 MannKind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
9283193, Sep 14 2005 MannKind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
9339615, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9358352, Jun 13 2008 MannKind Corporation Dry powder drug delivery system and methods
9364436, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
9364619, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
9393372, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
9446001, Sep 14 2005 MannKind Corporation Increasing drug affinity for crystalline microparticle surfaces
9446133, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9511198, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9610351, Oct 24 2011 MannKind Corporation; Torrey Pines Institute for Molecular Studies Methods and compositions for treating pain
9630930, Jun 12 2009 MannKind Corporation Diketopiperazine microparticles with defined specific surface areas
9655850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
9662461, Jun 13 2008 MannKind Corporation Dry powder drug delivery system and methods
9675674, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
9700690, Mar 20 2002 MannKind Corporation Inhalation apparatus
9706944, Nov 03 2009 MannKind Corporation Apparatus and method for simulating inhalation efforts
9717689, Sep 14 2005 MannKind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
9796688, Aug 20 2004 MannKind Corporation Catalysis of diketopiperazine synthesis
9801925, Jun 29 1999 MannKind Corporation Potentiation of glucose elimination
9802012, Jul 12 2012 MannKind Corporation Dry powder drug delivery system and methods
9925144, Jul 18 2013 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
9943571, Aug 11 2008 MannKind Corporation Use of ultrarapid acting insulin
9983108, Mar 11 2009 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
D560793, Aug 06 2003 Pfizer Limited Inhaler
D569967, Aug 06 2003 Pfizer Limited Inhaler
D582544, Aug 09 2007 COVIS PHARMA B V Metered dose inhaler
D613395, May 23 2008 OTSUKA PHARMACEUTICAL CO , LTD; Otsuka Techno Corporation Inhaler
D613396, May 23 2008 OTSUKA PHARMACEUTICAL CO , LTD; Otsuka Techno Corporation Inhaler
D613397, May 23 2008 OTSUKA PHARMACEUTICAL CO , LTD; Otsuka Techno Corporation Inhaler
D614024, Oct 27 2006 Vectura Limited; VECTURA DELIVERY DEVICES LIMITED Dispenser
D623054, Apr 28 2006 Vectura Limited; VECTURA DELIVERY DEVICES LIMITED Dispenser
D629505, Dec 01 2008 MannKind Corporation Dry powder inhaler
D629506, Dec 01 2008 MannKind Corporation Dry powder inhaler
D629886, Dec 01 2008 MannKind Corporation Dry powder inhaler
D629887, Dec 01 2008 MannKind Corporation Dry powder inhaler
D629888, Dec 01 2008 MannKind Corporation Dry powder inhaler
D635659, May 04 2010 Adamis Pharmaceuticals Corporation Inhaler
D635660, May 04 2010 Adamis Pharmaceuticals Corporation Inhalation device
D636073, May 04 2010 Adamis Pharmaceuticals Corporation Inhaler
D636485, Nov 18 2009 Adamis Pharmaceuticals Corporation Inhaler
D643529, Oct 09 2009 VECTURA DELIVERY DEVICES LIMITED Inhaler having cover
D645734, Apr 28 2006 VECTURA DELIVERY DEVICES LIMITED Dispenser
D646965, Oct 27 2006 VECTURA DELIVERY DEVICES LIMITED Dispenser
D647195, Oct 09 2009 VECTURA DELIVERY DEVICES LIMITED Inhaler having cover
D647196, Oct 09 2009 VECTURA DELIVERY DEVICES LIMITED Inhaler having cover
D654805, Mar 10 2011 R J REYNOLDS TOBACCO COMPANY Spray dispensing container
D656606, Mar 23 2011 Novartis AG Inhaler
D657045, Mar 23 2011 Novartis AG Inhaler
D657048, Mar 23 2011 Novartis AG Inhaler
D657049, Mar 23 2011 Novartis AG Inhaler
D661795, Apr 08 2010 VECTURA DELIVERY DEVICES LIMITED Inhaler having cover
D669791, May 19 2011 R J REYNOLDS TOBACCO COMPANY Spray dispensing container
D669792, Mar 10 2011 R J REYNOLDS TOBACCO COMPANY Spray dispensing container
D673260, Nov 18 2009 Adamis Pharmaceuticals Corporation Inhalation device
D677377, Nov 18 2009 Adamis Pharmaceuticals Corporation Inhaler
D693458, Oct 24 2011 VECTURA DELIVERY DEVICES LIMITED Inhaler
D745660, Mar 26 2010 Oriel Therapeutics, Inc. Dry powder inhaler
D855792, Jan 30 2013 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Inhaler device
D983354, Dec 21 2020 RPC Formatec GmbH Inhaler
D985760, Oct 05 2021 NEUTEC INHALER ILAC SANAYI VE TICARET A. S. Inhalation device
D986406, Jul 21 2020 NiPPharma Co., Ltd. Inhaler for powdered medicaments
Patent Priority Assignee Title
20020170560,
20030172927,
D276847, Sep 21 1981 Aktiebolaget Draco Medical aerosol inhalation device
D355029, Jan 21 1993 Boehringer Ingelheim International GmbH Inhaler
D452910, Jun 29 2000 Innovata Biomed Limited Inhaler
EP472598,
EP617629,
EP634184,
EP661070,
///////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Apr 01 2003CHIESI FARMACEUTICI S.P.A.(assignment on the face of the patent)
Jun 30 2003PINON, JOHNCHIESI FARMACEUTICI S P A ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0143860749 pdf
Jul 02 2003SHIRGAONKAR, SAMEERCHIESI FARMACEUTICI S P A ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0143860749 pdf
Jul 03 2003SMITH, CHRISTOPHER JAMESCHIESI FARMACEUTICI S P A ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0143860749 pdf
Jul 11 2003LYE, EMMA LESLEYCHIESI FARMACEUTICI S P A ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0143860749 pdf
Jul 11 2003ARLETT, BENCHIESI FARMACEUTICI S P A ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0143860749 pdf
Jul 11 2003SARKAR, MATTHEW NEILCHIESI FARMACEUTICI S P A ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0143860749 pdf
Jul 11 2003AHERN, DAVIDCHIESI FARMACEUTICI S P A ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0143860749 pdf
Jul 11 2003MIDDLETON, MAX WILLIAMCHIESI FARMACEUTICI S P A ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0143860749 pdf
Jul 11 2003BURGE, SIMONCHIESI FARMACEUTICI S P A ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0143860749 pdf
Jul 11 2003SMITH, SIMONCHIESI FARMACEUTICI S P A ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0143860749 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule